Alios BioPharma, Inc. is a biotechnology company located in San Francisco, California that is developing novel medicines that treat diseases in virology and oncology by activating pathways in the innate immune system. Alios is pursuing the development of both protein and small molecule therapeutics, each addressing major commercial market opportunities.

Events and Announcements

Latest News

May 23, 2008

Dr. Lawrence Blatt presents at C21 Bio Ventures conference; May 21-22, 2008

Read More...

May 16, 2008

EASL: DEVELOPMENT OF NOVEL HYPERGLYGOSYLATED TYPE 1 INTERFERONS:  (04/30/08)

Read More...